BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30621547)

  • 1. Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.
    Yang X; Li AN; Zhao XH; Liu XW; Wang SJ
    Int J Neurosci; 2019 Aug; 129(8):754-761. PubMed ID: 30621547
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
    Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
    Li Y; Song F; Liu W; Wang Y
    Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
    Li Z; Cui T; Shi W; Wang Q
    Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
    Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
    Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 12. Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
    Casault C; Alikhani K; Pillay N; Koch M
    J Neuroimmunol; 2015 Dec; 289():84-6. PubMed ID: 26616875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
    Li LH; Ma CC; Zhang HF; Lian YJ
    Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    Chen L; Su T; Liu Y
    BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
    Adhikari A; Subedi RC; Acharya S; Paudel R
    JNMA J Nepal Med Assoc; 2020 Jul; 58(227):487-490. PubMed ID: 32827010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limbic Encephalitis Associated with Anti-γ-aminobutyric Acid B Receptor Antibodies: A Case Series from China.
    Guan HZ; Ren HT; Yang XZ; Lu Q; Peng B; Zhu YC; Shao XQ; Hu YQ; Zhou D; Cui LY
    Chin Med J (Engl); 2015 Nov; 128(22):3023-8. PubMed ID: 26608981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
    Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
    Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
    Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
    Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
    Wang S; Wang J; Li B; Hu N; Jin Y; Han S; Shang X
    Front Immunol; 2023; 14():1191823. PubMed ID: 37304289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.